|
1
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haddad RI and Shin DM: Recent advances in
head and neck cancer. N Engl J Med. 359:1143–1154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Y and Kowdley KV: MicroRNAs in common
human diseases. Genomics Proteomics Bioinformatics. 10:246–253.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ranganathan K and Sivasankar V: MicroRNAs
- Biology and clinical applications. J Oral Maxillofac Pathol.
18:229–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gomes CC, de Sousa SF and Gomez RS:
MicroRNAs: Small molecules with a potentially role in oral squamous
cell carcinoma. Curr Pharm Des. 19:1285–1291. 2013.
|
|
10
|
Manikandan M, Deva Magendhra Rao AK,
Rajkumar KS, Rajaraman R and Munirajan AK: Altered levels of
miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral
squamous cell carcinoma and association with clinicopathological
characteristics. J Oral Pathol Med. Dec 8–2014.Epub ahead of print.
View Article : Google Scholar
|
|
11
|
Yoon AJ, Wang S, Shen J, Robine N,
Philipone E, Oster MW, Nam A and Santella RM: Prognostic value of
miR-375 and miR-214-3p in early stage oral squamous cell carcinoma.
Am J Transl Res. 6:580–592. 2014.PubMed/NCBI
|
|
12
|
Shiah SG, Hsiao JR, Chang WM, Chen YW, Jin
YT, Wong TY, Huang JS, Tsai ST, Hsu YM, Chou ST, et al:
Downregulated miR329 and miR410 promote the proliferation and
invasion of oral squamous cell carcinoma by targeting Wnt-7b.
Cancer Res. 74:7560–7572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tiwari A, Shivananda S, Gopinath KS and
Kumar A: Micro-RNA-125a reduces proliferation and invasion of oral
squamous cell carcinoma cells by targeting estrogen-related
receptor α: Implications for cancer therapeutics. J Biol Chem.
289:32276–32290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seike M, Goto A, Okano T, Bowman ED,
Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, et
al: MiR-21 is an EGFR-regulated anti-apoptotic factor in lung
cancer in never-smokers. Proc Natl Acad Sci USA. 106:12085–12090.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Zhang H, Zhao M, Lv Z, Zhang X,
Qin X, Wang H, Wang S, Su J, Lv X, et al: MiR-138 inhibits tumor
growth through repression of EZH2 in non-small cell lung cancer.
Cell Physiol Biochem. 31:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye XW, Yu H, Jin YK, Jing XT, Xu M, Wan ZF
and Zhang XY: miR-138 inhibits proliferation by targeting
3-phosphoinositide-dependent protein kinase-1 in non-small cell
lung cancer cells. Clin Respir J. 9:27–33. 2015. View Article : Google Scholar
|
|
17
|
Mitomo S, Maesawa C, Ogasawara S, Iwaya T,
Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu
N, et al: Downregulation of miR-138 is associated with
overexpression of human telomerase reverse transcriptase protein in
human anaplastic thyroid carcinoma cell lines. Cancer Sci.
99:280–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT:
MiR-138 induces cell cycle arrest by targeting cyclin D3 in
hepatocellular carcinoma. Carcinogenesis. 33:1113–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Long L, Huang G, Zhu H, Guo Y, Liu Y and
Huo J: Downregulation of miR-138 promotes colorectal cancer
metastasis via directly targeting TWIST2. J Transl Med. 11:2752013.
View Article : Google Scholar
|
|
20
|
Chen P, Zeng M, Zhao Y and Fang X:
Upregulation of Limk1 caused by microRNA-138 loss aggravates the
metastasis of ovarian cancer by activation of Limk1/cofilin
signaling. Oncol Rep. 32:2070–2076. 2014.PubMed/NCBI
|
|
21
|
Hogg RP, Honorio S, Martinez A,
Agathanggelou A, Dallol A, Fullwood P, Weichselbaum R, Kuo MJ,
Maher ER and Latif F: Frequent 3p allele loss and epigenetic
inactivation of the RASSF1A tumour suppressor gene from region
3p21.3 in head and neck squamous cell carcinoma. Eur J Cancer.
38:1585–1592. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Piccinin S, Gasparotto D, Vukosavljevic T,
Barzan L, Sulfaro S, Maestro R and Boiocchi M: Microsatellite
instability in squamous cell carcinomas of the head and neck
related to field cancerization phenomena. Br J Cancer.
78:1147–1151. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harvey KF, Pfleger CM and Hariharan IK:
The Drosophila Mst ortholog, hippo, restricts growth and cell
proliferation and promotes apoptosis. Cell. 114:457–467. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Edgar BA: From cell structure to
transcription: Hippo forges a new path. Cell. 124:267–273. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Overholtzer M, Zhang J, Smolen GA, Muir B,
Li W, Sgroi DC, Deng CX, Brugge JS and Haber DA: Transforming
properties of YAP, a candidate oncogene on the chromosome 11q22
amplicon. Proc Natl Acad Sci USA. 103:12405–12410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim
J, Xie J, Ikenoue T, Yu J, Li L, et al: Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hamaratoglu F, Gajewski K, Sansores-Garcia
L, Morrison C, Tao C and Halder G: The Hippo tumor-suppressor
pathway regulates apical-domain size in parallel to tissue growth.
J Cell Sci. 122:2351–2359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Snijders AM, Schmidt BL, Fridlyand J,
Dekker N, Pinkel D, Jordan RC and Albertson DG: Rare amplicons
implicate frequent deregulation of cell fate specification pathways
in oral squamous cell carcinoma. Oncogene. 24:4232–4242. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Seton-Rogers S: Oncogenes: All eyes on
YAP1. Nat Rev Cancer. 14:514–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu X, Jiang L, Wang A, Yu J, Shi F and
Zhou X: MicroRNA-138 suppresses invasion and promotes apoptosis in
head and neck squamous cell carcinoma cell lines. Cancer Lett.
286:217–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han L, Zhang G, Zhang N, Li H, Liu Y, Fu A
and Zheng Y: Prognostic potential of microRNA-138 and its target
mRNA PDK1 in sera for patients with non-small cell lung cancer. Med
Oncol. 31:1292014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang L, Liu X, Kolokythas A, Yu J, Wang
A, Heidbreder CE, Shi F and Zhou X: Downregulation of the Rho
GTPase signaling pathway is involved in the microRNA-138-mediated
inhibition of cell migration and invasion in tongue squamous cell
carcinoma. Int J Cancer. 127:505–512. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang L, Dai Y, Liu X, Wang C, Wang A,
Chen Z, Heidbreder CE, Kolokythas A and Zhou X: Identification and
experimental validation of G protein alpha inhibiting activity
polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous
cell carcinoma. Hum Genet. 129:189–197. 2011. View Article : Google Scholar :
|
|
34
|
Liu R, Huang S, Lei Y, Zhang T, Wang K,
Liu B, Nice EC, Xiang R, Xie K, Li J, et al: FGF8 promotes
colorectal cancer growth and metastasis by activating YAP1.
Oncotarget. 6:935–952. 2015.
|
|
35
|
Lee KW, Lee SS, Kim SB, Sohn BH, Lee HS,
Jang HJ, Park YY, Kopetz S, Kim SS, Oh SC, et al: Significant
association of oncogene YAP1 with poor prognosis and cetuximab
resistance in colorectal cancer patients. Clin Cancer Res.
21:357–364. 2015. View Article : Google Scholar :
|
|
36
|
India Project Team of the International
Cancer Genome Consortium: Mutational landscape of gingivo-buccal
oral squamous cell carcinoma reveals new recurrently-mutated genes
and molecular subgroups. Nat Commun. 4:28732013.PubMed/NCBI
|
|
37
|
Zhang L, Ye DX, Pan HY, Wei KJ, Wang LZ,
Wang XD, Shen GF and Zhang ZY: Yes-associated protein promotes cell
proliferation by activating Fos Related Activator-1 in oral
squamous cell carcinoma. Oral Oncol. 47:693–697. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu ZM, Xu YF, Su QJ, Du JD, Tan XL, Tu
YL, Tan JW and Jiao HB: Prognostic significance of microRNA-141
expression and its tumor suppressor function in human pancreatic
ductal adenocarcinoma. Mol Cell Biochem. 388:39–49. 2014.
View Article : Google Scholar
|
|
39
|
Zhang ZW, Men T, Feng RC, Li YC, Zhou D
and Teng CB: miR-375 inhibits proliferation of mouse pancreatic
progenitor cells by targeting YAP1. Cell Physiol Biochem.
32:1808–1817. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li H, Shang H, Shu D, Zhang H, Ji J, Sun
B, Li H and Xie Q: gga-miR-375 plays a key role in tumorigenesis
post subgroup J avian leukosis virus infection. PLoS One.
9:e908782014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Christensen LL, Holm A, Rantala J,
Kallioniemi O, Rasmussen MH, Ostenfeld MS, Dagnaes-Hansen F, Øster
B, Schepeler T, Tobiasen H, et al: Functional screening identifies
miRNAs influencing apoptosis and proliferation in colorectal
cancer. PLoS One. 9:e967672014. View Article : Google Scholar : PubMed/NCBI
|
